Typicality: | 0.401 |
Saliency: | 0.355 |
specifically | 6 | manner |
in the immune system | 4 | location |
of targeting cancer cells | 3 | manner |
drug → target → cell | 31 |
drug → target → specific cells | 8 |
drug → target → human cells | 4 |
negative | neutral | positive |
0.333 | 0.501 | 0.166 |
Raw frequency | 43 |
Normalized frequency | 0.355 |
Modifier score | 0.500 |
Perplexity | 257.142 |